All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF851 | Anti-Human TNFRSF13C (XW-851) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-851 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF852 | Anti-Human TNFRSF13C (XW-852) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-852 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF853 | Anti-Human TNFRSF13C (XW-853) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-853 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF854 | Anti-Human TNFRSF13C (XW-854) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-854 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF855 | Anti-Mouse TNFRSF13C (XW-855) m(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-855 | Human | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF856 | Anti-Mouse TNFRSF13C (XW-856) m(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-856 | Rat | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF857 | Anti-Human TNFRSF13C (XW-857) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-857 | Humanized | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1771 | Anti-Human TNFRSF13C (XW-851) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-851 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1772 | Anti-Human TNFRSF13C (XW-852) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-852 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1773 | Anti-Human TNFRSF13C (XW-853) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-853 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1774 | Anti-Human TNFRSF13C (XW-854) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-854 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1775 | Anti-Mouse TNFRSF13C (XW-855) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-855 | Human | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1776 | Anti-Mouse TNFRSF13C (XW-856) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-856 | Rat | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1777 | Anti-Human TNFRSF13C (XW-857) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-857 | Humanized | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2691 | Anti-Human TNFRSF13C (XW-851) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-851 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2692 | Anti-Human TNFRSF13C (XW-852) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-852 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2693 | Anti-Human TNFRSF13C (XW-853) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-853 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2694 | Anti-Human TNFRSF13C (XW-854) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-854 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2695 | Anti-Mouse TNFRSF13C (XW-855) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-855 | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2696 | Anti-Mouse TNFRSF13C (XW-856) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-856 | Rat | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION